evolcSign inStart free
Menu

Enterprise Therapeutics

Develops investigational medicines for people with cystic fibrosis and other respiratory diseases

Brighton, United KingdomFounded 2014enterprisetherapeutics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Enterprise Therapeutics

Enterprise Therapeutics is a clinical-stage biopharmaceutical company developing therapies for respiratory diseases. Its research targets the mechanisms of mucus congestion, including ion channels involved in mucus hydration and clearance.

Its pipeline includes ETD001, an investigational inhaled ENaC blocker for cystic fibrosis that has undergone a Phase 2 clinical trial. The company also researches compounds intended to reduce mucus production.

Founded in 2014, Enterprise Therapeutics is headquartered in Brighton and has an office in London. Its investors include Novartis Venture Fund, Versant, Forbion, IP Group, Epidarex and Panakes Partners.

Product: A pipeline of investigational muco-regulatory therapies, including ETD001 for cystic fibrosis.

Jobs at Enterprise Therapeutics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Epidarex Exeed

    Seeds early-stage life science ventures by developing breakthrough therapeutic research into investable assets
    Edinburgh, United KingdomBiotech & pharmaFounded 2019
    New on Evolc

  • Epitopea

    Develops off-the-shelf RNA cancer immunotherapies for patients with difficult-to-treat cancers
    Cambridge, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

  • Epsilogen

    Develops antibody-based cancer treatments, including a clinical candidate for ovarian cancer
    London, United KingdomBiotech & pharmaFounded 2016
    New on Evolc

  • Extracellular

    CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturing
    United KingdomBiotech & pharma1 open job
    New on EvolcSalary transparent

  • Exymes

    Enzyme-based DNA/RNA extraction reagents and kits for forensic, academic, veterinary and environmental labs
    Bournemouth, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • F2G

    Develops first-in-class antifungal medicines for rare, life-threatening fungal infections in patients with limited options
    Macclesfield, United KingdomBiotech & pharmaFounded 1998
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google reCAPTCHA
  • PHP
  • WordPress
  • jQuery
  • nginx